{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidlcmbjwyk2y2rvikoyh4ugmzhlnurqz73drlyiaosxmvq25jwjzu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhggtc3u7on2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiczp7pb7faorn53okkjx6oggkqsquflmmdzpmkfkec4xjb3y2vqx4"
    },
    "mimeType": "image/jpeg",
    "size": 604097
  },
  "path": "/news/2026-03-schizophrenia-biomarker-drug-candidate-cognitive.html",
  "publishedAt": "2026-03-19T11:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction. As a result, many patients are unable to work, rely on family for lifelong support, become homeless or, in some cases, experience suicidal thoughts and actions.",
  "title": "Schizophrenia study finds new biomarker, drug candidate to treat cognitive symptoms"
}